PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Food Safety Administration, Office of the Chief Medical Officer, Thoubal Wangma Taba, Thoubal District -795138, Manipur, India.\', \'Department of Pharmacology, Jawaharlal Nehru Institute of Medical Sciences, Porompat, Imphal East - 795010, Manipur, India.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2174/1389450121999201202110303
?:doi
?:hasPublicationType
?:journal
  • Current drug targets
is ?:pmid of
?:pmid
?:pmid
  • 33267759
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.906
?:rankingScore_hIndex
  • 89
is ?:relation_isRelatedTo_publication of
?:title
  • Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33267759>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33267759>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all